<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-10-07" version="193">
<accession>Q06413</accession>
<accession>C9JMZ0</accession>
<accession>D7F7N5</accession>
<accession>F8W7V7</accession>
<name>MEF2C_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="28">Myocyte-specific enhancer factor 2C</fullName>
</recommendedName>
<alternativeName>
<fullName evidence="29">Myocyte enhancer factor 2C</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="29">MEF2C</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="1546" last="1550">
<title>MEF2C, a MADS/MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex.</title>
<authorList>
<person name="Leifer D."/>
<person name="Krainc D."/>
<person name="Yu Y.-T."/>
<person name="McDermott J."/>
<person name="Breitbart R.E."/>
<person name="Heng J."/>
<person name="Neve R.L."/>
<person name="Kosofsky B."/>
<person name="Nadal-Ginard B."/>
<person name="Lipton S.A."/>
</authorList>
<dbReference type="PubMed" id="7679508"/>
<dbReference type="DOI" id="10.1073/pnas.90.4.1546"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<source>
<tissue>Fetal brain</tissue>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="2564" last="2577">
<title>hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors.</title>
<authorList>
<person name="McDermott J.C."/>
<person name="Cardoso M.C."/>
<person name="Yu Y.-T."/>
<person name="Andres V."/>
<person name="Leifer D."/>
<person name="Krainc D."/>
<person name="Lipton S.A."/>
<person name="Nadal-Ginard B."/>
</authorList>
<dbReference type="PubMed" id="8455629"/>
<dbReference type="DOI" id="10.1128/mcb.13.4.2564"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2008-05" db="EMBL/GenBank/DDBJ databases">
<title>Identification and characterization of a new splice variant of human MEF2C.</title>
<authorList>
<person name="Infantino V."/>
<person name="Convertini P."/>
<person name="Palmieri F."/>
<person name="Iacobazzi V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 5 AND 6)</scope>
<source>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="431" first="268" last="274">
<title>The DNA sequence and comparative analysis of human chromosome 5.</title>
<authorList>
<person name="Schmutz J."/>
<person name="Martin J."/>
<person name="Terry A."/>
<person name="Couronne O."/>
<person name="Grimwood J."/>
<person name="Lowry S."/>
<person name="Gordon L.A."/>
<person name="Scott D."/>
<person name="Xie G."/>
<person name="Huang W."/>
<person name="Hellsten U."/>
<person name="Tran-Gyamfi M."/>
<person name="She X."/>
<person name="Prabhakar S."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chan Y.M."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Martinez D."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nandkeshwar R."/>
<person name="Noonan J.P."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Priest J."/>
<person name="Ramirez L."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="Dickson M."/>
<person name="Cheng J.-F."/>
<person name="Eichler E.E."/>
<person name="Olsen A."/>
<person name="Pennacchio L.A."/>
<person name="Rokhsar D.S."/>
<person name="Richardson P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="15372022"/>
<dbReference type="DOI" id="10.1038/nature02919"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="7054" last="7066">
<title>BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C.</title>
<authorList>
<person name="Kato Y."/>
<person name="Kravchenko V.V."/>
<person name="Tapping R.I."/>
<person name="Han J."/>
<person name="Ulevitch R.J."/>
<person name="Lee J.-D."/>
</authorList>
<dbReference type="PubMed" id="9384584"/>
<dbReference type="DOI" id="10.1093/emboj/16.23.7054"/>
</citation>
<scope>PHOSPHORYLATION AT THR-293; THR-300 AND SER-419</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF THR-293; THR-300 AND SER-419</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="Nature" volume="386" first="296" last="299">
<title>Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation.</title>
<authorList>
<person name="Han J."/>
<person name="Jiang Y."/>
<person name="Li Z."/>
<person name="Kravchenko V.V."/>
<person name="Ulevitch R.J."/>
</authorList>
<dbReference type="PubMed" id="9069290"/>
<dbReference type="DOI" id="10.1038/386296a0"/>
</citation>
<scope>PHOSPHORYLATION AT THR-293; THR-300 AND SER-419</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF THR-293; THR-300 AND SER-419</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1998" name="Mol. Immunol." volume="35" first="445" last="458">
<title>Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes.</title>
<authorList>
<person name="Swanson B.J."/>
<person name="Jaeck H.-M."/>
<person name="Lyons G.E."/>
</authorList>
<dbReference type="PubMed" id="9798649"/>
<dbReference type="DOI" id="10.1016/s0161-5890(98)00058-3"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="7816" last="7827">
<title>HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor.</title>
<authorList>
<person name="Wang A.H."/>
<person name="Bertos N.R."/>
<person name="Vezmar M."/>
<person name="Pelletier N."/>
<person name="Crosato M."/>
<person name="Heng H.H."/>
<person name="Th'ng J."/>
<person name="Han J."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="10523670"/>
<dbReference type="DOI" id="10.1128/mcb.19.11.7816"/>
</citation>
<scope>INTERACTION WITH HDAC4</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="18534" last="18540">
<title>Big mitogen-activated kinase regulates multiple members of the MEF2 protein family.</title>
<authorList>
<person name="Kato Y."/>
<person name="Zhao M."/>
<person name="Morikawa A."/>
<person name="Sugiyama T."/>
<person name="Chakravortty D."/>
<person name="Koide N."/>
<person name="Yoshida T."/>
<person name="Tapping R.I."/>
<person name="Yang Y."/>
<person name="Yokochi T."/>
<person name="Lee J.D."/>
</authorList>
<dbReference type="PubMed" id="10849446"/>
<dbReference type="DOI" id="10.1074/jbc.m001573200"/>
</citation>
<scope>PHOSPHORYLATION BY MAPK7</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="10572" last="10577">
<title>Cloning and characterization of a histone deacetylase, HDAC9.</title>
<authorList>
<person name="Zhou X."/>
<person name="Marks P.A."/>
<person name="Rifkind R.A."/>
<person name="Richon V.M."/>
</authorList>
<dbReference type="PubMed" id="11535832"/>
<dbReference type="DOI" id="10.1073/pnas.191375098"/>
</citation>
<scope>INTERACTION WITH HDAC9</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="3974" last="3979">
<title>Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis.</title>
<authorList>
<person name="Okamoto S."/>
<person name="Li Z."/>
<person name="Ju C."/>
<person name="Scholzke M.N."/>
<person name="Mathews E."/>
<person name="Cui J."/>
<person name="Salvesen G.S."/>
<person name="Bossy-Wetzel E."/>
<person name="Lipton S.A."/>
</authorList>
<dbReference type="PubMed" id="11904443"/>
<dbReference type="DOI" id="10.1073/pnas.022036399"/>
</citation>
<scope>PROTEOLYTIC PROCESSING AT ASP-432</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ASP-432</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="8264" last="8275">
<title>Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.</title>
<authorList>
<person name="Zhu B."/>
<person name="Gulick T."/>
</authorList>
<dbReference type="PubMed" id="15340086"/>
<dbReference type="DOI" id="10.1128/mcb.24.18.8264-8275.2004"/>
</citation>
<scope>PHOSPHORYLATION AT SER-396</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF SER-396</scope>
<scope>FUNCTION OF ISOFORMS</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="2615" last="2622">
<title>MEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57.</title>
<authorList>
<person name="Kobarg C.B."/>
<person name="Kobarg J."/>
<person name="Crosara-Alberto D.P."/>
<person name="Theizen T.H."/>
<person name="Franchini K.G."/>
</authorList>
<dbReference type="PubMed" id="15862299"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.03.078"/>
</citation>
<scope>INTERACTION WITH HABP4</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="5004" last="5012">
<title>Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.</title>
<authorList>
<person name="Gocke C.B."/>
<person name="Yu H."/>
<person name="Kang J."/>
</authorList>
<dbReference type="PubMed" id="15561718"/>
<dbReference type="DOI" id="10.1074/jbc.m411718200"/>
</citation>
<scope>SUMOYLATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28749" last="28760">
<title>Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.</title>
<authorList>
<person name="Zhu B."/>
<person name="Ramachandran B."/>
<person name="Gulick T."/>
</authorList>
<dbReference type="PubMed" id="15834131"/>
<dbReference type="DOI" id="10.1074/jbc.m502491200"/>
</citation>
<scope>FUNCTION OF BETA DOMAIN</scope>
<scope>MUTAGENESIS OF SER-271; GLU-272; ASP-273; ASP-275; SER-387 AND SER-396</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="2273" last="2287">
<title>Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors.</title>
<authorList>
<person name="Gregoire S."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="15743823"/>
<dbReference type="DOI" id="10.1128/mcb.25.6.2273-2287.2005"/>
</citation>
<scope>SUMOYLATION AT LYS-391</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="3575" last="3582">
<title>Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.</title>
<authorList>
<person name="Ma K."/>
<person name="Chan J.K."/>
<person name="Zhu G."/>
<person name="Wu Z."/>
</authorList>
<dbReference type="PubMed" id="15831463"/>
<dbReference type="DOI" id="10.1128/mcb.25.9.3575-3582.2005"/>
</citation>
<scope>ACETYLATION AT LYS-116; LYS-119; LYS-234; LYS-239; LYS-252 AND LYS-264</scope>
<scope>INTERACTION WITH EP300</scope>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF LYS-116; LYS-119; LYS-234; LYS-239; LYS-252 AND LYS-264</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="BMC Biochem." volume="7" first="5" last="5">
<title>Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity.</title>
<authorList>
<person name="Kang J."/>
<person name="Gocke C.B."/>
<person name="Yu H."/>
</authorList>
<dbReference type="PubMed" id="16478538"/>
<dbReference type="DOI" id="10.1186/1471-2091-7-5"/>
</citation>
<scope>SUMOYLATION AT LYS-391</scope>
<scope>MUTAGENESIS OF LYS-391 AND SER-396</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="J. Med. Genet." volume="47" first="22" last="29">
<title>MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations.</title>
<authorList>
<person name="Le Meur N."/>
<person name="Holder-Espinasse M."/>
<person name="Jaillard S."/>
<person name="Goldenberg A."/>
<person name="Joriot S."/>
<person name="Amati-Bonneau P."/>
<person name="Guichet A."/>
<person name="Barth M."/>
<person name="Charollais A."/>
<person name="Journel H."/>
<person name="Auvin S."/>
<person name="Boucher C."/>
<person name="Kerckaert J.P."/>
<person name="David V."/>
<person name="Manouvrier-Hanu S."/>
<person name="Saugier-Veber P."/>
<person name="Frebourg T."/>
<person name="Dubourg C."/>
<person name="Andrieux J."/>
<person name="Bonneau D."/>
</authorList>
<dbReference type="PubMed" id="19592390"/>
<dbReference type="DOI" id="10.1136/jmg.2009.069732"/>
</citation>
<scope>INVOLVEMENT IN MRD20</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-228; SER-240 AND SER-445</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="825" last="830">
<title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.</title>
<authorList>
<person name="Carvill G.L."/>
<person name="Heavin S.B."/>
<person name="Yendle S.C."/>
<person name="McMahon J.M."/>
<person name="O'Roak B.J."/>
<person name="Cook J."/>
<person name="Khan A."/>
<person name="Dorschner M.O."/>
<person name="Weaver M."/>
<person name="Calvert S."/>
<person name="Malone S."/>
<person name="Wallace G."/>
<person name="Stanley T."/>
<person name="Bye A.M."/>
<person name="Bleasel A."/>
<person name="Howell K.B."/>
<person name="Kivity S."/>
<person name="Mackay M.T."/>
<person name="Rodriguez-Casero V."/>
<person name="Webster R."/>
<person name="Korczyn A."/>
<person name="Afawi Z."/>
<person name="Zelnick N."/>
<person name="Lerman-Sagie T."/>
<person name="Lev D."/>
<person name="Moeller R.S."/>
<person name="Gill D."/>
<person name="Andrade D.M."/>
<person name="Freeman J.L."/>
<person name="Sadleir L.G."/>
<person name="Shendure J."/>
<person name="Berkovic S.F."/>
<person name="Scheffer I.E."/>
<person name="Mefford H.C."/>
</authorList>
<dbReference type="PubMed" id="23708187"/>
<dbReference type="DOI" id="10.1038/ng.2646"/>
</citation>
<scope>VARIANT ARG-39</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="216" last="225">
<title>Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes.</title>
<authorList>
<consortium name="Clinical Study Group"/>
<person name="Parrini E."/>
<person name="Marini C."/>
<person name="Mei D."/>
<person name="Galuppi A."/>
<person name="Cellini E."/>
<person name="Pucatti D."/>
<person name="Chiti L."/>
<person name="Rutigliano D."/>
<person name="Bianchini C."/>
<person name="Virdo S."/>
<person name="De Vita D."/>
<person name="Bigoni S."/>
<person name="Barba C."/>
<person name="Mari F."/>
<person name="Montomoli M."/>
<person name="Pisano T."/>
<person name="Rosati A."/>
<person name="Guerrini R."/>
</authorList>
<dbReference type="PubMed" id="27864847"/>
<dbReference type="DOI" id="10.1002/humu.23149"/>
</citation>
<scope>VARIANT ARG-36</scope>
</reference>
<comment type="function">
<text evidence="4 10 11 14 15 21 22">Transcription activator which binds specifically to the MEF2 element present in the regulatory regions of many muscle-specific genes. Controls cardiac morphogenesis and myogenesis, and is also involved in vascular development. Enhances transcriptional activation mediated by SOX18. Plays an essential role in hippocampal-dependent learning and memory by suppressing the number of excitatory synapses and thus regulating basal and evoked synaptic transmission. Crucial for normal neuronal development, distribution, and electrical activity in the neocortex. Necessary for proper development of megakaryocytes and platelets and for bone marrow B-lymphopoiesis. Required for B-cell survival and proliferation in response to BCR stimulation, efficient IgG1 antibody responses to T-cell-dependent antigens and for normal induction of germinal center B-cells. May also be involved in neurogenesis and in the development of cortical architecture (By similarity). Isoforms that lack the repressor domain are more active than isoform 1.</text>
</comment>
<comment type="subunit">
<text evidence="4 7 9 16">Forms a complex with class II HDACs in undifferentiating cells. On myogenic differentiation, HDACs are released into the cytoplasm allowing MEF2s to interact with other proteins for activation. Interacts with EP300 in differentiating cells; the interaction acetylates MEF2C leading to increased DNA binding and activation (By similarity). Interacts with HDAC7 and CARM1 (By similarity). Interacts with HDAC4 and HDAC9; the interaction with HDACs represses transcriptional activity (PubMed:10523670, PubMed:11535832). Interacts with LPIN1. Interacts with MYOCD. Interacts with AKAP13 (By similarity). Interacts with FOXK1; the interaction inhibits MEF2C transactivation activity (By similarity). Interacts (via N-terminus) with HABP4; this interaction decreases DNA-binding activity of MEF2C in myocardial cells in response to mechanical stress (PubMed:15862299). Interacts with JPH2; interaction specifically takes place with the Junctophilin-2 N-terminal fragment cleavage product of JPH2 (By similarity). Interacts (via MADS box) with SOX18 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2684075">
<id>Q06413</id>
</interactant>
<interactant intactId="EBI-11953488">
<id>P56524-2</id>
<label>HDAC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2684075">
<id>Q06413</id>
</interactant>
<interactant intactId="EBI-356910">
<id>Q9H1R3</id>
<label>MYLK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="3">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasm</location>
<location evidence="3">Sarcoplasm</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q06413-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q06413-2</id>
<name>2</name>
<name>Muscle</name>
<sequence type="described" ref="VSP_006248"/>
</isoform>
<isoform>
<id>Q06413-3</id>
<name>3</name>
<name>hMEF2C-delta32</name>
<name>Brain</name>
<sequence type="described" ref="VSP_006249"/>
</isoform>
<isoform>
<id>Q06413-4</id>
<name>4</name>
<sequence type="described" ref="VSP_043339 VSP_006248"/>
</isoform>
<isoform>
<id>Q06413-5</id>
<name>5</name>
<sequence type="described" ref="VSP_045478 VSP_006248"/>
</isoform>
<isoform>
<id>Q06413-6</id>
<name>6</name>
<sequence type="described" ref="VSP_046251 VSP_006248"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="23">Expressed in brain and skeletal muscle.</text>
</comment>
<comment type="developmental stage">
<text>Expression is highest during the early stages of postnatal development, at later stages levels greatly decrease.</text>
</comment>
<comment type="domain">
<text evidence="2">The beta domain, missing in a number of isoforms, is required for enhancement of transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="2 8 11 12 13 17 21 22">Phosphorylation on Ser-59 enhances DNA binding activity (By similarity). Phosphorylation on Ser-396 is required for Lys-391 sumoylation and inhibits transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="2">Acetylated by p300 on several sites in diffentiating myocytes. Acetylation on Lys-4 increases DNA binding and transactivation (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="12 13 17">Sumoylated on Lys-391 with SUMO2 but not by SUMO1 represses transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="10">Proteolytically cleaved in cerebellar granule neurons, probably by caspase 7, following neurotoxicity. Preferentially cleaves the CDK5-mediated hyperphosphorylated form which leads to neuron apoptosis and transcriptional inactivation.</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-02856">
<name>Mental retardation, autosomal dominant 20</name>
<acronym>MRD20</acronym>
<description>A disorder characterized by severe mental retardation, absent speech, hypotonia, poor eye contact and stereotypic movements. Dysmorphic features include high broad forehead with variable small chin, short nose with anteverted nares, large open mouth, upslanted palpebral fissures and prominent eyebrows. Some patients have seizures.</description>
<dbReference type="MIM" id="613443"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="28">Belongs to the MEF2 family.</text>
</comment>
<dbReference type="EMBL" id="L08895">
<property type="protein sequence ID" value="AAA59578.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S57212">
<property type="protein sequence ID" value="AAB25838.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FM163484">
<property type="protein sequence ID" value="CAQ57795.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL833268">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL833274">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008525">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC008835">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47244.1">
<molecule id="Q06413-6"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47245.1">
<molecule id="Q06413-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54877.1">
<molecule id="Q06413-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54878.1">
<molecule id="Q06413-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS78034.1">
<molecule id="Q06413-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS87313.1">
<molecule id="Q06413-3"/>
</dbReference>
<dbReference type="PIR" id="A47284">
<property type="entry name" value="A47284"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124477.1">
<molecule id="Q06413-6"/>
<property type="nucleotide sequence ID" value="NM_001131005.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180276.1">
<molecule id="Q06413-5"/>
<property type="nucleotide sequence ID" value="NM_001193347.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180277.1">
<molecule id="Q06413-4"/>
<property type="nucleotide sequence ID" value="NM_001193348.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180278.1">
<property type="nucleotide sequence ID" value="NM_001193349.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180279.1">
<molecule id="Q06413-1"/>
<property type="nucleotide sequence ID" value="NM_001193350.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001294931.1">
<molecule id="Q06413-2"/>
<property type="nucleotide sequence ID" value="NM_001308002.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002388.2">
<molecule id="Q06413-1"/>
<property type="nucleotide sequence ID" value="NM_002397.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005248568.1">
<molecule id="Q06413-1"/>
<property type="nucleotide sequence ID" value="XM_005248511.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006714682.1">
<property type="nucleotide sequence ID" value="XM_006714619.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006714688.1">
<molecule id="Q06413-5"/>
<property type="nucleotide sequence ID" value="XM_006714625.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011541698.1">
<molecule id="Q06413-1"/>
<property type="nucleotide sequence ID" value="XM_011543396.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011541702.1">
<property type="nucleotide sequence ID" value="XM_011543400.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864967.1">
<molecule id="Q06413-6"/>
<property type="nucleotide sequence ID" value="XM_017009478.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864968.1">
<property type="nucleotide sequence ID" value="XM_017009479.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864969.1">
<property type="nucleotide sequence ID" value="XM_017009480.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016864970.1">
<property type="nucleotide sequence ID" value="XM_017009481.1"/>
</dbReference>
<dbReference type="SMR" id="Q06413"/>
<dbReference type="BioGRID" id="110372">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="DIP" id="DIP-40857N"/>
<dbReference type="ELM" id="Q06413"/>
<dbReference type="IntAct" id="Q06413">
<property type="interactions" value="25"/>
</dbReference>
<dbReference type="MINT" id="Q06413"/>
<dbReference type="STRING" id="9606.ENSP00000340874"/>
<dbReference type="iPTMnet" id="Q06413"/>
<dbReference type="PhosphoSitePlus" id="Q06413"/>
<dbReference type="BioMuta" id="MEF2C"/>
<dbReference type="DMDM" id="2500875"/>
<dbReference type="jPOST" id="Q06413"/>
<dbReference type="MassIVE" id="Q06413"/>
<dbReference type="MaxQB" id="Q06413"/>
<dbReference type="PeptideAtlas" id="Q06413"/>
<dbReference type="PRIDE" id="Q06413"/>
<dbReference type="ProteomicsDB" id="10911"/>
<dbReference type="ProteomicsDB" id="30019"/>
<dbReference type="ProteomicsDB" id="58439">
<molecule id="Q06413-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58440">
<molecule id="Q06413-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58441">
<molecule id="Q06413-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58442">
<molecule id="Q06413-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="755">
<property type="antibodies" value="1262 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4208"/>
<dbReference type="Ensembl" id="ENST00000340208">
<molecule id="Q06413-5"/>
<property type="protein sequence ID" value="ENSP00000340874"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000424173">
<molecule id="Q06413-6"/>
<property type="protein sequence ID" value="ENSP00000389610"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000437473">
<molecule id="Q06413-1"/>
<property type="protein sequence ID" value="ENSP00000396219"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000504921">
<molecule id="Q06413-1"/>
<property type="protein sequence ID" value="ENSP00000421925"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000508569">
<molecule id="Q06413-2"/>
<property type="protein sequence ID" value="ENSP00000423597"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000514015">
<molecule id="Q06413-3"/>
<property type="protein sequence ID" value="ENSP00000424606"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000514028">
<molecule id="Q06413-3"/>
<property type="protein sequence ID" value="ENSP00000426665"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000625674">
<molecule id="Q06413-6"/>
<property type="protein sequence ID" value="ENSP00000487430"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000628656">
<molecule id="Q06413-4"/>
<property type="protein sequence ID" value="ENSP00000487311"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000629612">
<molecule id="Q06413-2"/>
<property type="protein sequence ID" value="ENSP00000486554"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000636294">
<molecule id="Q06413-1"/>
<property type="protein sequence ID" value="ENSP00000490473"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000636998">
<molecule id="Q06413-3"/>
<property type="protein sequence ID" value="ENSP00000490630"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000637732">
<molecule id="Q06413-3"/>
<property type="protein sequence ID" value="ENSP00000490241"/>
<property type="gene ID" value="ENSG00000081189"/>
</dbReference>
<dbReference type="GeneID" id="4208"/>
<dbReference type="KEGG" id="hsa:4208"/>
<dbReference type="UCSC" id="uc003kjj.4">
<molecule id="Q06413-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4208"/>
<dbReference type="DisGeNET" id="4208"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000081189.13"/>
<dbReference type="GeneCards" id="MEF2C"/>
<dbReference type="HGNC" id="HGNC:6996">
<property type="gene designation" value="MEF2C"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000081189">
<property type="expression patterns" value="Tissue enhanced (skeletal)"/>
</dbReference>
<dbReference type="MalaCards" id="MEF2C"/>
<dbReference type="MIM" id="600662">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613443">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q06413"/>
<dbReference type="OpenTargets" id="ENSG00000081189"/>
<dbReference type="Orphanet" id="228384">
<property type="disease" value="5q14.3 microdeletion syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30734"/>
<dbReference type="eggNOG" id="KOG0014">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157492"/>
<dbReference type="InParanoid" id="Q06413"/>
<dbReference type="KO" id="K04454"/>
<dbReference type="OMA" id="LVMPNSR"/>
<dbReference type="OrthoDB" id="729387at2759"/>
<dbReference type="PhylomeDB" id="Q06413"/>
<dbReference type="TreeFam" id="TF314067"/>
<dbReference type="PathwayCommons" id="Q06413"/>
<dbReference type="Reactome" id="R-HSA-198753">
<property type="pathway name" value="ERK/MAPK targets"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2151201">
<property type="pathway name" value="Transcriptional activation of mitochondrial biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-525793">
<property type="pathway name" value="Myogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9022707">
<property type="pathway name" value="MECP2 regulates transcription factors"/>
</dbReference>
<dbReference type="SignaLink" id="Q06413"/>
<dbReference type="SIGNOR" id="Q06413"/>
<dbReference type="BioGRID-ORCS" id="4208">
<property type="hits" value="27 hits in 895 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MEF2C">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="MEF2C"/>
<dbReference type="GenomeRNAi" id="4208"/>
<dbReference type="Pharos" id="Q06413">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q06413"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="Q06413">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000081189">
<property type="expression patterns" value="Expressed in middle temporal gyrus and 241 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q06413">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q06413">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098794">
<property type="term" value="C:postsynapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016528">
<property type="term" value="C:sarcoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003680">
<property type="term" value="F:AT DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071837">
<property type="term" value="F:HMG box domain binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1990837">
<property type="term" value="F:sequence-specific double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001782">
<property type="term" value="P:B cell homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042100">
<property type="term" value="P:B cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050853">
<property type="term" value="P:B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001568">
<property type="term" value="P:blood vessel development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001974">
<property type="term" value="P:blood vessel remodeling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014898">
<property type="term" value="P:cardiac muscle hypertrophy in response to stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003211">
<property type="term" value="P:cardiac ventricle formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060536">
<property type="term" value="P:cartilage morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030154">
<property type="term" value="P:cell differentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048667">
<property type="term" value="P:cell morphogenesis involved in neuron differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0071277">
<property type="term" value="P:cellular response to calcium ion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071498">
<property type="term" value="P:cellular response to fluid shear stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071374">
<property type="term" value="P:cellular response to parathyroid hormone stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071560">
<property type="term" value="P:cellular response to transforming growth factor beta stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035984">
<property type="term" value="P:cellular response to trichostatin A"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002062">
<property type="term" value="P:chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048703">
<property type="term" value="P:embryonic viscerocranium morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001958">
<property type="term" value="P:endochondral ossification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001013">
<property type="term" value="P:epithelial cell proliferation involved in renal tubule morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060079">
<property type="term" value="P:excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0002467">
<property type="term" value="P:germinal center formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072102">
<property type="term" value="P:glomerulus morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001947">
<property type="term" value="P:heart looping"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006959">
<property type="term" value="P:humoral immune response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030318">
<property type="term" value="P:melanocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030224">
<property type="term" value="P:monocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007521">
<property type="term" value="P:muscle cell fate determination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007517">
<property type="term" value="P:muscle organ development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0014902">
<property type="term" value="P:myotube differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043537">
<property type="term" value="P:negative regulation of blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030279">
<property type="term" value="P:negative regulation of ossification"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904753">
<property type="term" value="P:negative regulation of vascular associated smooth muscle cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904706">
<property type="term" value="P:negative regulation of vascular associated smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905563">
<property type="term" value="P:negative regulation of vascular endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0072160">
<property type="term" value="P:nephron tubule epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0014033">
<property type="term" value="P:neural crest cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048666">
<property type="term" value="P:neuron development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030182">
<property type="term" value="P:neuron differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001764">
<property type="term" value="P:neuron migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0001649">
<property type="term" value="P:osteoblast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003151">
<property type="term" value="P:outflow tract morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030220">
<property type="term" value="P:platelet formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010694">
<property type="term" value="P:positive regulation of alkaline phosphatase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030890">
<property type="term" value="P:positive regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000987">
<property type="term" value="P:positive regulation of behavioral fear response"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030501">
<property type="term" value="P:positive regulation of bone mineralization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000727">
<property type="term" value="P:positive regulation of cardiac muscle cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060045">
<property type="term" value="P:positive regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071864">
<property type="term" value="P:positive regulation of cell proliferation in bone marrow"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000111">
<property type="term" value="P:positive regulation of macrophage apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0051149">
<property type="term" value="P:positive regulation of muscle cell differentiation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045663">
<property type="term" value="P:positive regulation of myoblast differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045666">
<property type="term" value="P:positive regulation of neuron differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045669">
<property type="term" value="P:positive regulation of osteoblast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001016">
<property type="term" value="P:positive regulation of skeletal muscle cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048643">
<property type="term" value="P:positive regulation of skeletal muscle tissue development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003138">
<property type="term" value="P:primary heart field specification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000311">
<property type="term" value="P:regulation of AMPA receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0060998">
<property type="term" value="P:regulation of dendritic spine development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0002634">
<property type="term" value="P:regulation of germinal center formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045652">
<property type="term" value="P:regulation of megakaryocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043523">
<property type="term" value="P:regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0046928">
<property type="term" value="P:regulation of neurotransmitter secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:2000310">
<property type="term" value="P:regulation of NMDA receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0060297">
<property type="term" value="P:regulation of sarcomere organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051963">
<property type="term" value="P:regulation of synapse assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0060025">
<property type="term" value="P:regulation of synaptic activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048167">
<property type="term" value="P:regulation of synaptic plasticity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0051966">
<property type="term" value="P:regulation of synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0061333">
<property type="term" value="P:renal tubule morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002931">
<property type="term" value="P:response to ischemia"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="Alzheimers_University_of_Toronto"/>
</dbReference>
<dbReference type="GO" id="GO:0060021">
<property type="term" value="P:roof of mouth development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003139">
<property type="term" value="P:secondary heart field specification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003185">
<property type="term" value="P:sinoatrial valve morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035914">
<property type="term" value="P:skeletal muscle cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007519">
<property type="term" value="P:skeletal muscle tissue development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051145">
<property type="term" value="P:smooth muscle cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0055012">
<property type="term" value="P:ventricular cardiac muscle cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00265">
<property type="entry name" value="MADS_MEF2_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.1810.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR022102">
<property type="entry name" value="HJURP_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR033896">
<property type="entry name" value="MADS_MEF2-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR002100">
<property type="entry name" value="TF_MADSbox"/>
</dbReference>
<dbReference type="InterPro" id="IPR036879">
<property type="entry name" value="TF_MADSbox_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF12347">
<property type="entry name" value="HJURP_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00319">
<property type="entry name" value="SRF-TF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00404">
<property type="entry name" value="MADSDOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00432">
<property type="entry name" value="MADS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55455">
<property type="entry name" value="SSF55455"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00350">
<property type="entry name" value="MADS_BOX_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50066">
<property type="entry name" value="MADS_BOX_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Myocyte-specific enhancer factor 2C" id="PRO_0000199433">
<location>
<begin position="1"/>
<end position="473"/>
</location>
</feature>
<feature type="domain" description="MADS-box" evidence="6">
<location>
<begin position="3"/>
<end position="57"/>
</location>
</feature>
<feature type="DNA-binding region" description="Mef2-type" evidence="5">
<location>
<begin position="58"/>
<end position="86"/>
</location>
</feature>
<feature type="region of interest" description="Beta domain">
<location>
<begin position="271"/>
<end position="278"/>
</location>
</feature>
<feature type="region of interest" description="Transcription repressor">
<location>
<begin position="368"/>
<end position="399"/>
</location>
</feature>
<feature type="compositionally biased region" description="Lys-rich (basic)">
<location>
<begin position="4"/>
<end position="31"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="146"/>
<end position="183"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="28">
<location>
<begin position="432"/>
<end position="433"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="4"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK2" evidence="4">
<location>
<position position="59"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="98"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="106"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="110"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="116"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="119"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="228"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="234"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="239"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="240"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="252"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="264"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK14" evidence="21 22">
<location>
<position position="293"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK14" evidence="21 22">
<location>
<position position="300"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5" evidence="11">
<location>
<position position="396"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAPK7" evidence="21 22">
<location>
<position position="419"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="445"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="13 17">
<location>
<position position="391"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_043339" evidence="27">
<location>
<begin position="87"/>
<end position="134"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_046251" evidence="24">
<original>TLRKKGLNGCDSPDPDADDSVGHSPESEDKYRKINEDIDLMISRQRLC</original>
<variation>ALNKKENKGCESPDPDSSYALTPRTEEKYKKINEEFDNMIKSHKIP</variation>
<location>
<begin position="87"/>
<end position="134"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_045478" evidence="24">
<original>VGHSPESEDKYRKINEDIDLMISRQRLC</original>
<variation>ALNKKENKGCESPDPDSSYALTPRTEEKYKKINEEFDNMIKSHKIP</variation>
<location>
<begin position="107"/>
<end position="134"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 4, isoform 5 and isoform 6." id="VSP_006248" evidence="24 25 26 27">
<location>
<begin position="271"/>
<end position="278"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_006249" evidence="25">
<location>
<begin position="368"/>
<end position="399"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with infantile onset epileptic encephalopathy and autism spectrum disorder." id="VAR_078228" evidence="20">
<original>S</original>
<variation>R</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with infantile onset epileptic encephalopathy and autism spectrum disorder; dbSNP:rs796052729." id="VAR_078621" evidence="19">
<original>C</original>
<variation>R</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetylation. Further reduction in acetylation; when associated with R-119. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-119; R-234; R-239; R-252 and R-262." evidence="14">
<original>K</original>
<variation>R</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetylation. Further reduction in acetylation; when associated with R-119. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-234; R-239; R-252 and R-262." evidence="14">
<original>K</original>
<variation>R</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-239; R-252 and R-264." evidence="14">
<original>K</original>
<variation>R</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-252 and R-264." evidence="14">
<original>K</original>
<variation>R</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-239 and R-264." evidence="14">
<original>K</original>
<variation>R</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced acetylation. Complete loss of acetylation, 15% less transactivation activity and slightly reduced DNA binding; when associated with R-116; R-119; R-234; R-239 and R-252." evidence="14">
<original>K</original>
<variation>R</variation>
<location>
<position position="264"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on transcriptional activation." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with N-273 and N-275." evidence="15">
<original>E</original>
<variation>Q</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with Q-272 and N-275." evidence="15">
<original>D</original>
<variation>N</variation>
<location>
<position position="273"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced transcriptional activation. Completely abolishes transcriptional activation; when associated with Q-272 and N-273." evidence="15">
<original>D</original>
<variation>N</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes MAPK14-mediated phosphorylation. No effect on MAPK7-mediated phosphorylation; when associated with A-300." evidence="21 22">
<original>T</original>
<variation>A</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes MAPK14-mediated phosphorylation. No effect on MAPK7-mediated phosphorylation; when associated with A-293." evidence="21 22">
<original>T</original>
<variation>A</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in transactivational activation for isoforms with or without the beta domain." evidence="15">
<original>S</original>
<variation>A</variation>
<location>
<position position="387"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation." evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes sumoylation. Enhanced transcriptional activity." evidence="11 15 17">
<original>S</original>
<variation>A</variation>
<variation>C</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in transactivational activation for isoforms with or without the beta domain." evidence="11 15 17">
<original>S</original>
<variation>A</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation. No effect on transcriptional activity." evidence="11 15 17">
<original>S</original>
<variation>E</variation>
<location>
<position position="396"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on MAPK14-mediated phosphorylation. Abolishes MAPK7-mediated phosphorylation and reduces transactivation activity." evidence="21 22">
<original>S</original>
<variation>A</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes cleavage by caspase 7." evidence="10">
<original>D</original>
<variation>A</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AL833268." ref="4" evidence="28">
<original>I</original>
<variation>T</variation>
<location>
<position position="390"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="A0A096MJY4"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8CFN5"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00251"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10523670"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10849446"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11535832"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11904443"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340086"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15561718"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15743823"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15831463"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15834131"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15862299"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16478538"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19592390"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23708187"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27864847"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9069290"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9384584"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9798649"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7679508"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8455629"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="28" type="ECO:0000305"/>
<evidence key="29" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:6996"/>
</source>
</evidence>
<sequence length="473" mass="51221" checksum="A7982020BB8C8949" modified="1997-11-01" version="1">MGRKKIQITRIMDERNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNSTNKLFQYASTDMDKVLLKYTEYNEPHESRTNSDIVETLRKKGLNGCDSPDPDADDSVGHSPESEDKYRKINEDIDLMISRQRLCAVPPPNFEMPVSIPVSSHNSLVYSNPVSSLGNPNLLPLAHPSLQRNSMSPGVTHRPPSAGNTGGLMGGDLTSGAGTSAGNGYGNPRNSPGLLVSPGNLNKNMQAKSPPPMNLGMNNRKPDLRVLIPPGSKNTMPSVSEDVDLLLNQRINNSQSAQSLATPVVSVATPTLPGQGMGGYPSAISTTYGTEYSLSSADLSSLSGFNTASALHLGSVTGWQQQHLHNMPPSALSQLGACTSTHLSQSSNLSLPSTQSLNIKSEPVSPPRDRTTTPSRYPQHTRHEAGRSPVDSLSSCSSSYDGSDREDHRNEFHSPIGLTRPSPDERESPSVKRMRLSEGWAT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

